Association Between Proton Pump Inhibitor Therapy and Clostridium difficile Infection in a Meta-Analysis

PPI therapy is associated with a 2-fold increase in risk for CDI. Because of the observational nature of the analyzed studies, we were not able to study the causes of this association. Further studies are needed to determine the mechanisms by which PPI therapy might increase risk for CDI.